MS Patients Using RebiSmart Injection Device Stick to Treatment Schedules, Study Shows – Multiple Sclerosis News Today

Posted: Published on April 18th, 2017

This post was added by Dr. Richardson

vH(>Ek7%KY]lNH@I;O?!I6"2iXUwOtYD~DfdFFFDFF>_Q4vSJ~,1? PjE -a-3gJ?$cqPQ V4:m >*vql9(7Qb#AIuh8U/nb>7ouB4]qF'UNU#o4=`NN_~B4-)kHEX%!}[d+Oy'K(aF1G9x!!Qgo_y=u? 0e'42y*6.MWSw0nP'ae=+tU!LudG;{Wohz~7`[WCk=o8PF- 6oFiF?=215=^1ev!w tgx9vx0j$TQx &"L~v:!Q"+ -;H+"2G;RnBzcvT|:#o?*;TOf #r=b "ma fWcOKBX tR+}{1-hVmri] )~P5b00sFsS*%hW}wp+pPo/@xT@rWltbRATYT7%)Jb~JUny bUDepp0AG<8,o778W0JqM^+|*M9V N qQQ` XnP4p@iAjV[Fow+?T#G*lh!O As@u`piMcfjr6i|>4*5UG )_QW]p`VsJ:>%vkl*AeXU%@@p=y*|e(,)Lo5}4GI4u^~^BMH"wN?7:w0Y([ wk[2dJ`wg(O1+qzD40[0_'H[[ v%hX AZ}cEyVDqsD%Uv>zF@ [W2 h(@T ^sePl`D97A5S?XN}/vww?^<3uUYB4)0mGL*I@'fl o1N4w}zsZ8 1Cs$A$YUEhcWg/v]|elg2b@)Hh;4QcH&vhX%N-a*Ifse YfX@J$]Q %F5ZC5"j%(<@ANC/c`%ghp=bFCxEck}M4dH K(L8;kOlk <7+!?]n](j#7% ]"":Q4D.+~gz8+'vOPAG9.n%AsO@6hSkSi}T3#nN ?Jm Ko>adj8#j]ny,C)+kA[$TXzUB(kWq/ty$t &06skpq.h'[{<`F;n,j hQl|RmZXN{I,_@SqG?~_n'@cz~=`qKjHPMGo? aM/vjcCS.}F`9+pp<0nm<`+:)J.m): DvXz5t]^0(SI@7 (xp"o 2y2f'qbKG>J!!ANCZRocg L9c}~Z9Axz_l4>)UeL5A@IE{7;2hYPt q9M;`-H'yPpHVCX5"*l|FB@.Vou;@ nFr Ko[zh9~4zQKfoj':T"?BG_)*09LC6 KY*?s$NSW59jSHw-c!2thL=OEz:zTim`@ms,:O#[OL {nvlw;'g[]TT#8NK7>Wy1,FKY.ED^)*}^`Y=QK8SadJ9E hY~e.eaxRh!40 EFMR3*PUJ2$sSnY}-NO)GK*2;Z2,~2TXJ;2ziQmME_K`>bTBLD4@hr]?xAC|A,g&ix $7th%/P*'Z5qBT4m#7_?]%GY?h+m~bECL.)Th 9he>gjx`@.S+&=f>C3p{WiCXS:)A.4Q@'.=E0S^h!913eaM E+UD]wlVLd_Rz`T>a+hyQ"IOFKU6&HnkX$W~e*I,vR B6Xvz-avWw`G# Aie#>c<=e22Fd~Aib0)]5m$ q7ZpAn_y| {`XE;M];;]_>{5%O4^9x"~)< (0D#'0|@^5iPUPYZWG S!6c`t[C:~M+%D4l&XQB)Q*|;~byTg#?x%4,3g2o!~ICctUl3~m6Fz/FJVr ;c5LZ&,G@ }@2AZj[:-C:jLQ+sMfXjYlQ#Nm@AwK'PG?u%Y|S,E{='vFgVW^.QzCqlqD87~_/CF~,0XcL4~3Lb H>x#WRyRj+owz/j@aG2FIZ~%u]/z0GZG51eeyl|y{ny p`3b/*lFc%;hwjh}QEXhqv*>;d@+R]"a+!Q]>H8l@Z&5$+zDOAgCluwkt8-NU vJJ>bDHZ@?eav>-go7b7~ZblSEbH /l-h<=PX7!ezn/g%nV!cW,b%KD(qV jf4q]E9<$AEf6V:ke]]q`pm-K:`nky+b`"Q^@KS/[ ;QLy,CQ^ 'c?he^L`N|)5C{h$d_`5F[4zbF12sqbx^ (%QE6;cI076F8|&$Et;]d1fL ^5{Ce#)jTj ^Nx~n:qBfSx83t tD-zw{+xkk !&RER2vio7m!+ 3sB:,L%j< 8mv5 6v2ZXS/frHKA}IHu(Eh3Z,EHB9`:IW0qqlc(c+Ja@:Y,I"}cZEWbR7x8uuh2x LdrG u>l!;tJP#M- McGIEL`oT,AWctl.PH~ol-@FnlZK3aE@rmbK3*cUaY0!p~/d&h`*LV>8Ua#UCRh<$qrM$V~qBOI81rJLV M}{c3eG'4Jk|]'>],N=CN=Lf,chOa."nR:<4 -[{h;ArJil'Of 22#L- 9?b:^=R.?OU/vWNc1;b[9B,WtDeLvVdy_#47lDy5EP^0z5 y~)fw9''G?7X]buF1= <Ng`W=rJ/d2z,c vA[BD-Xld3<4n=c?8;mLgKlLNcJ5|IG` )eH%VrZ+Gaq;hnp}IFsb&LuGVZi|jh6>b0=I"Y36Uo| SBfqca{y}|]vm-;o&vtFU"ci}9,Pat6q =s,vZbC:/"E8Es(jC<{EYTJzf*1=T-A2YO*vZdk^QV^+7jm0IFe8X9WNWk&+ps>Z5+nKR{im#"n74q_>Vb|{F114Al@ Smo0f8*wsK%Mt:@WP1)X3zE+!DCW/Xmd )0Qx>9, R@$P5Lux7 Vr;q<|uZ8s~j }*lPu<,-NL)`w`]`w!-M?@aS^lVNN]tjKG*~E6N]>@RG?U)VDd?^U `/1`MRm 6KooA&w%cPg7mn&~;`!KQ9V,I~e5)xu;x:.AI9IDUFaW6FUMHYJ (]$-9mY}$xV>Yfs^Yn`7IyVV{(x&pY^UgG&dB`@7I`syo5qdk*~*&j`B|_bs4}>fPy[k1c5bS76wq;| D3s~mTUY9s/TX>eN}*nA-,Xq-wUPh!/)--h*V08hSUkS&04E &ZsH,M; 8' Gt$-SQa mOu.R+E>#PyUmm3r k[M9xd$=;J?B osE5O2uep?dy5///TZMhJosYB[*wLnp-Ks<5& pd:j-p@_*Z[IRFGm lw9+YnBvPfL6G,%X(MmBA)ZF,Nkw~,D^Zh*^vva`[hh%s`ueb|.ZBWIREm(aiSYN6<'r#g17)^b3zI< 7YL +9FSl_ p3s/T%XP[z1Y5| &=|;FHOd0&Htr0p^ 'lzc?<&V7%-Xwn VLrQo+!- h0a{}@ +rQ9QeWCsQzF=g=}f'y6s,GutR6K|,|H#1|!6EO7-ojd<"~ e)_n#FWnt4EDgokzK3;;2kA/n?'{Z&1XM(xo(>iV> > [mmlL-4 r@+51cncoyNY26$iD`h`G6mQXK}fFgm4#S8.Dk|hln.JBai"+z~ u]D;h5yva{5[xGY9,d|.9.iJ6#Cv0{Rh^SFTB)TRLLPAMB{VQ)t?m#K#j"z>5QMrXLt<&=><6 vAs' o&hF4?5%GWg2TUI6]Dy;/d~}DN_k)vo[|y`qwW|{u9K_YQ4"mCDOC-Q,KB]{Z[ &hh@}`2Lc*PD<)1NQm,/o&fG0j8gC{OkXGbnJw)FJ%vXjEvf)^?F IU/U <4lU35=0G/$U>#}1|(TxV%=LJN-eKcPz7?"~CqD6Ga}h hN4On;Ac49ciGnCy*Gxw:LXlH0}@~d:XDKCXu+'*i03 a^Cxy GI=&*Ux& y@0vz-;M|R =oq8*'QS&1 >}+)KA`Q&wC 0vIst~LK 4fW% VW;F Ifhw{isODIl4pqS5 _ x>pU. mr5 Z;{`qSbO#{,H[ZX-~cL^Gx J5xXWHhS>Ml|OvOXKyt{C(] wHL:G^#h kFgMMMX[88D2.x/gT?r{Mo>^Wj^1H2>1 (S)R/!6-r?)jx iQuh5 ai(x UcErzVNp6tk`)ar/@u]}a`Xf0.WaM"Adi,/-chT: SUKD-jj$&@+9Hu231r/ McIG"B$YmZZHacTD%k)5%bR*bb:w!h~R+=Dl-qB$lI"'{zq]uqGw[fM6aht{Fm|F=4,=(3A@B*@a1=-l1o+m2Ehb)u2$G*!X`b l>8^w+|

@&s+4gh|d`4VMZT%jU+g3D'!^Hvw Sf^@x6Od?4TN@]!09@/#qXCW6Mi{^UC6 d99el[N$X&p|CF]3Cv4g`/NO^2 l1xFdC,}Fv@aBHg }T*GYC_)Jjc4W2XbpAa/PpD!1$=b&PT{hL{J D'"c9. Li4c8UOBOvpw,a:(Ae:dRB9rHMZ2w9iY?_f5@wK@i 5FY 4acm3}F{Z5vz[l=,hzh9]PL%*3hN&`<|p&&`*[ 0eAO%/>{6oa.{lKe9M_Q"?f"`}>OX%!39KOD/:f#HS ^@bjQv#xaQ Vk4PhV[.{o/N__zsx| vD~o 20;F+M'A_)c#9$#Fc|)F I zbJ)KHtfe"rRF??*,&s$C:3~OBh!SiDB)TK8PJN8=D!%8-*J|@3Jwt;Bp[-kIWA bO=Ei-itM'F~K.So_%s>M"2"PDB['+DN}@' J <|N ?>z/B bSE?L"5r>T(n.zr]Ig:NL-3-K;5z`G~<"Gc%,f84S,:.[co`u"]O35ZM4~3Ng3REV<_n4I>~MlA7 z0XbC1gLG7K1!J/u~%O gb.A=k)'.;DskemnZE|S/[>9 5/>y_x4~xZjJ#,y#6Jz(S@i Z4xI"9asd&M5b_wf*9H" d5,ksOcSKQv0K#vso^ P6jfG&(W`ru"ItoEMSX[CUOx:{$iG(EI!z :=d4e}OF^NK2f5$[U#Ef6z3h[v6N`E`8h|^>st!yGiGlPgx^?&77#_im<55%"$ZPsE~1DDz`d/R~LplqKC+8UQ*L(axkxthu^wW9To5M_m- qI`!d? ghN% Fs5%HC&zZ-zz~6UQ[:_ZZ7{&aKMD6rQ3Up0`Cx|2F*YnA`Z4 L0/h WeEM2u|+]Rp{h vP/^p,}gQ/:}WnO9{5}MO+RWUGyrl A;{t1O&)lo=N~}0c5>glB3GtUUb~-njVM Xu^*XcE4H]b?0AN,B yq1b0=! c+^W5'yW9wrso?QxAF(5u9BW)v`4 = q+Kp-ubx ~4y;J$.V@G*+MBK.adXY?|n{X#M;EX-^$;B]uZue{B*u^;ZW^v#o=[l1kmi157 __;hjOj,3Iy)= ~vDG_z6Gq$Gq$G3$"0Eg%!Y1`;I|d5KAgo]fE;=Q/t*gqkJa#.]M r_3}-S&t?j`3idPv+ ou})34+a3yzG#-DO6qe;7W"ZW7m%t Y$7U=`,ybC=x}ir>WfY2&x%TCs=`VOa4b7A)1b` KzT Q]|1B CI=BO=.m2214NAph&hX6A.Pa} !ayAlB (0Z['#Q6{x}|AU3W]g>E^=B|{mB;,Q16qpK1(.HJ;y[>N|@s- D.~wcMg7L|v!kDzl6ZF30>qS9W7P||'ZfnVkn/I%N"Q6a&xUIBZ_*;5SUX]N}odl=5{vB+Y|(?:A pR*Ry#8ZFZ0&>?`+/_'^']vr``$y?.$]g6OEyqk >~Tf'U6zM, JjR{Jk #r6A+0"mn.>-JGttJxtJ;d|IEN$dy?WYNQs9<}{c1&E!"w}&s`!!>3)BK*j2|>|ig}hYr@r J/`e0JHpa+dveZ,jt3 mC k*`WvMb#$FhIJN@hS'[M;2:Pw<;{}1@`sDob'.?-~4w7f"_@*D|XR)T2JU dpQAW~@;r5 *iwS(]Ap `U*%B@]2J>:"ITs2,c$~<~lP:tqW>;)i-Zs5:oE,jVzkCq6tW =8@$(*e}^{4.N2 Q{__e>:uwq 7}!z]o=yo~5 ]onICm`g ]kpYv$Zg4}[F|A{nDM`, NXyy cwfC &~@O$gaj[Hh*Pppu/I(]u,KV|= 4&!e(?W_N_~nwYTi8)7 MDh`<,:~>X_#/c;(1TVc5]` vF;TJqoGkTLUZN]ZfX"RI4b@L{c07/O_pqtu :b;[jz 5ky]}z9_08@Y[=1w=/&7C3kmI`6>;>Wm~^9Q_Rr~nS1$ ]4]cMUEQ`cpP@B:HHXj%Bd&x% hw3gMXgTazo`eCXnbp|g&&=wVTxe~#O+|K`~?~uOI__}~Wi$t?Of3VR=4*~!#7% z.^ J2+;LN!g~]Tvc;HT?iNSouRg xtK||="TMa;9iRTafza[% 3o/:XmOKPNPCuD60ZHO~ Bd{i}JUB L$O%$"FN/ /if'f '-TtHv0gr:#7z;iyVVKoc` U6;5aPU wq!0u6MFBFG9d

The rest is here:
MS Patients Using RebiSmart Injection Device Stick to Treatment Schedules, Study Shows - Multiple Sclerosis News Today

Related Posts
This entry was posted in MS Treatment. Bookmark the permalink.

Comments are closed.